#None #Toronto #Drug Development #Webinar Insights #KinetiSol Technology

Enhancing Late-Stage Drug Development with KinetiSol Technology

In an upcoming free webinar, "Overcoming Late-Stage Formulations & Manufacturing Challenges with KinetiSol Technology," industry professionals will explore how KinetiSol can significantly enhance bioavailability and streamline manufacturing processes for late-stage drug development. Scheduled for November 6, 2025, this enlightening session will be hosted by Dave Miller, PhD, Chief Scientific Officer at AustinPx.

The Challenges in Drug Development

Many drug developers today continue to face substantial obstacles when dealing with poorly soluble compounds, especially as they transition from early clinical development to late-stage trials. While spray-dried dispersions (SDDs) are commonly used in the initial phases due to their rapid formulation pace and regulatory familiarity, they present considerable formulation and manufacturing limitations as the process unfolds.

Issues such as:

• - High Pill Burden: Increased reliance on numerous pills can be overwhelming for patients.
• - Inefficient Solvent Use: Excessive solvent application leads to waste and logistical hurdles.
• - Scale-Up Problems: These hurdles often create roadblocks for programs trying to advance past Phase II trials.

KinetiSol™ Dispersions (KSDs) as a Solution

KinetiSol technology stands out by employing a solvent-free, high-energy fusion process that mitigates common scale-up challenges. This method greatly expands the formulation design space, allowing practitioners to develop more effective and robust drug products. By converting SDDs to KSDs, drug developers witness marked improvements in manufacturing attributes and patient compliance.

During the webinar, Dr. Miller will present case studies showcasing the conversion of low-loading SDDs into high-performing KSDs that offer six times greater bioavailability, improved tablet properties, and a reduction in overall pill burden. These successes highlight the transformative potential KinetiSol technology holds for the pharmaceutical industry.

Attendee Benefits

Participants will:

• - Gain insights on overcoming formulation limitations using KinetiSol.
• - Understand the importance of solvent-free processes in enhancing scalability.
• - Learn from a real-world case study highlighting KinetiSol’s superior outcomes.

Register Now

This webinar is a valuable opportunity for those involved in pharmaceutical, biotechnology, and healthcare sectors to stay abreast of the latest developments in drug formulation strategies. Interested attendees are encouraged to register to gain critical insights that could improve their late-stage drug development processes. For more details and registration, please visit Xtalks' website.

About Xtalks

Xtalks provides educational webinars and content for global life science, food, healthcare, and medical device industries. By attending webinars like this one, professionals can ensure they remain updated on industry trends, regulations, and innovations. Sign up today to secure your spot and be part of this engaging discussion on advancing drug development with KinetiSol technology.